Veranova: A CDMO that manages complexity with confidence.
01 2Veranova, L.P.
02 6Cambrex Charles City, Inc
03 1Curia New York, Inc.
04 1Siegfried USA, LLC
05 1SpecGx LLC
01 1AMPHETAMINE ASPARTATE
02 2Amphetamine Aspartate
03 1Amphetamine Aspratate Monohydrate
04 5Phenyl-2-(R,S)-Aminopropane Aspartate
05 1Phenyl-2-(R,S)-Aminopropane L-Aspartate
06 1Racemic Amphetamine Aspartate
01 1Ireland
02 1Switzerland
03 9U.S.A
NDC Package Code : 49812-0061
Start Marketing Date : 1999-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 49812-0295
Start Marketing Date : 2021-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 59116-1960
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 59116-1961
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 59116-1962
Start Marketing Date : 2012-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 59116-1963
Start Marketing Date : 2013-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 59116-1964
Start Marketing Date : 2015-09-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-4990
Start Marketing Date : 2015-08-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0406-3993
Start Marketing Date : 2013-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
AMPHETAMINE ASPARTATE MONOHYDRATE
NDC Package Code : 0792-3937
Start Marketing Date : 2023-07-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Amphetamine Aspartate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amphetamine Aspartate, including repackagers and relabelers. The FDA regulates Amphetamine Aspartate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amphetamine Aspartate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amphetamine Aspartate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amphetamine Aspartate supplier is an individual or a company that provides Amphetamine Aspartate active pharmaceutical ingredient (API) or Amphetamine Aspartate finished formulations upon request. The Amphetamine Aspartate suppliers may include Amphetamine Aspartate API manufacturers, exporters, distributors and traders.
click here to find a list of Amphetamine Aspartate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Amphetamine Aspartate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Amphetamine Aspartate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Amphetamine Aspartate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Amphetamine Aspartate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Amphetamine Aspartate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Amphetamine Aspartate suppliers with NDC on PharmaCompass.
We have 5 companies offering Amphetamine Aspartate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?